Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)
The purpose of this initiative is to incentivize small businesses to generate new technologies and products for delivering nucleic acids into cells and tissues for the purpose of treatment or prevention of human disease.
Related Programs
Discovery and Applied Research for Technological Innovations to Improve Human Health
Department of Health and Human ServicesNational Center for Advancing Translational Sciences
Department of Health and Human ServicesAllergy, Immunology and Transplantation Research
Department of Health and Human ServicesMicrobiology and Infectious Diseases Research
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: National Institutes of Health
Estimated Funding: Not Available
Office: National Institutes of Health
Estimated Funding: Not Available
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/pa-files/PAR-17-035.html
Additional Information of Eligibility:
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/pa-files/PAR-17-035.html
Contact:
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Agency Email:
FBOWebmaster@OD.NIH.GOV
Date Posted:
2016-10-27
Application Due Date:
2019-09-05
Archive Date:
2019-10-06
Social Entrepreneurship
Spotlight
Energy Giants Go Public on Carbon Pollution Pricing Strategies
Some of the biggest public companies in the United States, including Wal-Mart, Walt Disney Co., Microsoft, have adopted carbon pollution pricing strategies.
Learn How to Identify and Avoid Grant Scams
